Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2022

Nov 28, 2022

30786_dirs_2022-11-28_cdada282-b9e7-4795-a323-408d20b14a44.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2022-11-07

Reporting Person: Allison Schwartz (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-07 Bio-Rad B Common Stock G 42 Acquired 3890 Direct